Efficacy of SF 68 in the treatment of acute diarrhea - A placebo-controlled trial

Scandinavian Journal of Gastroenterology

Volumn 31, Issue 9, 1996, Pages 887-891

  Buydens, P ^a   Debeuckelaere, S ^b  

^a Algemeen Stedelijk Ziekenhuis   (Belgium)

^b NONE

Author keywords

Acute diarrhea; Lactc acid bacteria; Probiotics; SF 68 strain

Indexed keywords

BIOFLORIN; UNCLASSIFIED DRUG;

ACUTE DIARRHEA; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ENTEROCOCCUS; FEMALE; HUMAN; INTESTINE FLORA; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STRAIN DIFFERENCE;

EID: 0029788058     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365529609051997     Document Type: Article

References (18)

1. DuPont HL. Review article: Infectious diarrhea. Aliment Pharmacol Ther 1994;8:3-13.
2. Simon GL, Gorbach SL. The human intestinal microflora. Dig Dis Sci 1986;31:147S-62S.
3. Fuller R. Probiotics in human medicine. Gut 1991;32:439-42.
4. Goldin BR, Gorbach SL, Saxelin M, Barakat S, Gualtieri L, Salminen S. Survival of lactobacillus species in human gastrointestinal tract. Dig Dis Sci 1992;37:121-8.
5. Lewenstein A, Frigerio G, Moroni M. Biological properties of SF 68, a new approach for treatment of diarrheal disease. Curr Ther Res 1979;26:967-81.
6. Gorbach SL. Lactic acid bacteria and human health. Ann Intern Med 1990;22:37-41.
7. Lidbeck A, Nord CE. Lactobacilli and the normal human anaerobic microflora. Clin Infect Dis 1993;16 Suppl 4:5181-7.
8. Schiraldi O, Di Bari C, Trotta F. Le traitment par Streptococcus faecium des porteurs asymptomatiques de Salmonelles. Med Hyg 1982;40:445-6.
9. Mitra AK, Rabbani GH. A double-blind, controlled trial of Bioflorin (Streptococcus faecium SF 68) in adults with acute diarrhea due to Vibrio cholerae and entertoxigenic Eschecrichia coli. Gastroenterology 1990;99:1149-52.
10. Bellomo G, Mangiagli A, Nicastro L, Frigerio G. A controlled double-blind study of SF 68 strain as a new biological preparation for the treatment of diarrhoea in pediatrics. Curr Ther Res 1980;28:927-36.
11. Isolauri E, Juntunen M, Rautanen T, Sillanaukee P, Koivula T. A human Lactobacillus strain (Lactobacillus casei sp strain GG) promotes recovery from acute diarrhea in children. Pediatrics 1991;88:90-7.
12. Saavedra JM, Bauman NA, Oung I, Perman JA, Yolken RH. Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhea and shedding of rotavirus. Lancet 1994;344:1046-9.
13. Isolauri E, Kaila M, Mykkanen H, Ling WH, Salminen S. Oral bacteriotherapy for viral gastroenteritis. Dig Dis Sci 1994;39: 595-600.
14. Oksanen PJ, Salminen S, Saxelin M, Hamalainen P, Ihantola-Vormisto A, Murasniemi-Isoviita, et al. Prevention of traveller's diarrhea by lactobacillus. Ann Med 1990;22:53-6.
15. Camarri E, Belvisi A, Guidoni G, Marini G, Frigerio G. A double-blind comparison of two different treatments for acute enteritis in adults. Chemotherapy 1981;27:466-70.
16. Frigerio G. A lactic acid producer enterococcus in the prevention of antibiotic-associated diarrhea in the treatment of acute diarrheal disorders: a double-blind multicentre placebo-controlled clinical trial. Dig Dis Sci 1986;31 Suppl:496S.
17. Wunderlich PF, Braun L, Fumagalli I, D'Apuzzo V, Heini F, Karly M, et al. Double-blind report on the efficacy of lactic acid-producing Enterococcus SF 68 in the prevention of antibiotic-associated diarrhea and in the treatment of acute diarrhea. J Int Med Res 1989;17:333-8.
18. Brink TB, Minekus M, Bol J, Huis in t'Veld JNH. Production of antibacterial compounds by lactobacilli. FEMS Microbial Rev 1987;46:67.